|
NRBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.598400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.723650E-03 |
| Normal-vs-Stage2 |
3.024800E-01 |
| Normal-vs-Stage3 |
1.144500E-02 |
| Normal-vs-Stage4 |
6.556600E-04 |
| Stage1-vs-Stage2 |
4.086000E-01 |
| Stage1-vs-Stage3 |
9.828000E-01 |
| Stage1-vs-Stage4 |
1.019960E-01 |
| Stage2-vs-Stage3 |
4.325000E-01 |
| Stage2-vs-Stage4 |
7.290100E-02 |
| Stage3-vs-Stage4 |
1.388360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.622100E-04 |
| Normal-vs-AfricanAmerican |
1.782590E-01 |
| Normal-vs-Asian |
1.68547999999102E-05 |
| Caucasian-vs-AfricanAmerican |
3.222400E-01 |
| Caucasian-vs-Asian |
1.337720E-02 |
| AfricanAmerican-vs-Asian |
3.156800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.422100E-03 |
| Normal-vs-Female |
1.648860E-04 |
| Male-vs-Female |
2.076200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.316200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.979400E-04 |
| Normal-vs-Age(61-80Yrs) |
5.062400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.925800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.586400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.659200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.740600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.416800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.990600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.693400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.423180E-04 |
| Normal-vs-Grade 2 |
1.877190E-03 |
| Normal-vs-Grade 3 |
1.483750E-02 |
| Normal-vs-Grade 4 |
2.795900E-04 |
| Grade 1-vs-Grade 2 |
4.876400E-02 |
| Grade 1-vs-Grade 3 |
5.238500E-03 |
| Grade 1-vs-Grade 4 |
4.561400E-01 |
| Grade 2-vs-Grade 3 |
5.026800E-01 |
| Grade 2-vs-Grade 4 |
5.125900E-02 |
| Grade 3-vs-Grade 4 |
2.346500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.756700E-03 |
| Normal-vs-ccB subtype |
3.657300E-03 |
| ccA subtype-vs-ccB subtype |
4.908400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.256020E-03 |
| Normal-vs-N1 |
3.016200E-02 |
| N0-vs-N1 |
6.106100E-02 |
|
|
